MTOR and breast cancer: To further verify the relation between PI3K/AKT/mTOR/c-myc signaling pathway and STIL-driven malignant behaviors in BC, we activated the AKT pathway in STIL+/+ and STIL−/− cell lines with SC79 (AKT activating agent).